BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22904338)

  • 1. Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients.
    Mishra NN; Bayer AS; Moise PA; Yeaman MR; Sakoulas G
    J Infect Dis; 2012 Oct; 206(8):1160-7. PubMed ID: 22904338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
    Mishra NN; McKinnell J; Yeaman MR; Rubio A; Nast CC; Chen L; Kreiswirth BN; Bayer AS
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4012-8. PubMed ID: 21709105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.
    Sakoulas G; Guram K; Reyes K; Nizet V; Zervos M
    J Clin Microbiol; 2014 Jun; 52(6):2172-4. PubMed ID: 24648548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
    Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
    Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Okumura CY; Thienphrapa W; Olson J; Nonejuie P; Dam Q; Dhand A; Pogliano J; Yeaman MR; Hensler ME; Bayer AS; Nizet V
    J Mol Med (Berl); 2014 Feb; 92(2):139-49. PubMed ID: 24297496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
    Rose WE; Fallon M; Moran JJ; Vanderloo JP
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4422-7. PubMed ID: 22687502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
    Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC; Sancak B; Gür D
    Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptide exposure and reduced susceptibility to daptomycin: insights into a complex genetic puzzle.
    Kelley WL; Lew DP; Renzoni A
    J Infect Dis; 2012 Oct; 206(8):1153-6. PubMed ID: 22904340
    [No Abstract]   [Full Text] [Related]  

  • 16. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.
    Moise PA; Forrest A; Bayer AS; Xiong YQ; Yeaman MR; Sakoulas G
    J Infect Dis; 2010 Jan; 201(2):233-40. PubMed ID: 20001853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.
    Charlton CL; Hindler JA; Turnidge J; Humphries RM
    J Clin Microbiol; 2014 Nov; 52(11):3898-905. PubMed ID: 25143569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.
    Ji S; Jiang S; Wei X; Sun L; Wang H; Zhao F; Chen Y; Yu Y
    J Infect Dis; 2020 Mar; 221(Suppl 2):S243-S252. PubMed ID: 32176794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
    Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.